LURASIDONE-D8 HCL

Code: L-035-1ML D2-231

General description

Marketed under the trade name Latuda®, Lurasidone is a new atypical antipsychotic developed for the treatment of schizophrenia. This stabl...


read more

Your Price
€230.00 1ML
€282.90 inc. VAT
REQUEST

General description

Marketed under the trade name Latuda®, Lurasidone is a new atypical antipsychotic developed for the treatment of schizophrenia. This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including clinical toxicology, forensic testing, or pharmaceutical research.

Legal Information

Latuda is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.

Snap-N-Spike is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

application(s)clinical testing
concentration100 µg/mL in methanol (as free base)
feature(Snap-N-Spike®)
formliquid
formatsingle component solution
gradecertified reference material
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.